Application of IL-2 therapy to target T regulatory cell function
about
LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activityThe Concise Guide to PHARMACOLOGY 2013/14: catalytic receptors.Dendritic cells decreased the concomitant expanded Tregs and Tregs related IL-35 in cytokine-induced killer cells and increased their cytotoxicity against leukemia cells.IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154-CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized MiceChallenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy.Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers.IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells1α,25-dihydroxyvitamin D3 in combination with transforming growth factor-β increases the frequency of Foxp3⁺ regulatory T cells through preferential expansion and usage of interleukin-2Regulatory T cells control NK cells in an insulitic lesion by depriving them of IL-2.IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis.Current advances in T-cell-based cancer immunotherapyAntibodies to Interleukin-2 Elicit Selective T Cell Subset Potentiation through Distinct Conformational Mechanisms.IL-2/α-IL-2 Complex Treatment Cannot Be Substituted for the Adoptive Transfer of Regulatory T cells to Promote Bone Marrow Engraftment.Role of CD4+ Foxp3+ Regulatory T Cells in Protection Induced by a Live Attenuated, Replicating Type I Vaccine Strain of Toxoplasma gondii.Interleukin-2/Anti-Interleukin-2 Immune Complex Attenuates Cardiac Remodeling after Myocardial Infarction through Expansion of Regulatory T Cells.Expression, Identification and Characterize of CD25-Binding Epitope Modified Human IL-2 in Pichia pastoris.DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.Targeting regulatory T cells in cytokine-induced killer cell cultures (Review).Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcomeT-cell-based immunotherapy of autoimmune diseases.Nanomedicine and cancer immunotherapy - targeting immunosuppressive cells.Planes, Trains, and Automobiles: Perspectives on CAR T Cells and Other Cellular Therapies for Hematologic Malignancies.Prophylactic Interleukin-2 Treatment Prevents Fetal Gut Inflammation and Injury in an Ovine Model of Chorioamnionitis.Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection.Transcription factor c-Rel is indispensable for generation of thymic but not of peripheral Foxp3+ regulatory T cells.Regulatory T Cell Therapy for Ischemic Stroke: how far from Clinical Translation?AhR activation increases IL-2 production by alloreactive CD4+ T cells initiating the differentiation of mucosal-homing Tim3+ Lag3+ Tr1 cells.Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice.A Unique Population: Adipose-Resident Regulatory T Cells
P2860
Q28544395-1F40AFD7-C427-4EB0-B079-DC493AC79D61Q30486741-D178082F-7064-4797-ABE2-8A3898A9CC58Q31157715-EA7065E4-C6F2-49FB-80F2-CCD98F1C8B30Q33586165-1B5BAC62-FB65-4AF6-B18D-6641419272D1Q33811204-79CECB61-C623-44D3-AF13-B35E0F83A30EQ33870728-ECDA5C8E-4782-4ED4-A3CF-7BEF9E21074AQ34053939-F325D608-A639-4768-BAE4-D208C3E8AA5CQ34065797-AEA66D60-41D8-45B3-9BAA-0EE559417262Q34651528-411008AF-4C88-4B05-AB57-65F02D7E1B37Q34749483-B82D9E70-0109-4B29-8C69-57AE61EA642DQ35215158-F6E63D0F-0024-45A4-9D96-5DFBD063113DQ35630914-65623D28-736A-4D3D-B3FA-019FBC172051Q35885490-DD6C8871-EAC9-4B82-9D7C-F60BD61FD131Q35947458-47C520BC-D6B3-44B6-B514-3F67F23E88D8Q36814572-78FE87D7-22C1-48FA-9275-97ACF251A207Q36946354-682EF045-2198-4B89-80B2-DFE8D964ACC8Q37095161-FE05FD56-D193-41EB-B212-10C499A41084Q37708451-39C56BDA-D0C2-4163-926D-028E2F749634Q37725393-292B4CB6-69A4-48D5-A494-048967FAC88CQ38089940-4A6AF4AA-D26D-434F-A0A9-D39E494066E2Q38603362-CD1487B6-5FF6-4072-BE6B-3C1E04F89E16Q38823260-36FE5285-0AFE-4475-BFCC-FBB6C1B82D78Q40909567-26FFEB83-22B9-40AC-8387-C9A006154AC1Q41085383-35490316-FC01-4789-A9B3-DE526E813BC6Q41592849-DD8F6E39-E392-4C9F-8F92-6252F24F9FB6Q41658163-D4D2E402-0868-4FCE-9AFA-CE8C608F788AQ47917089-ABF540DF-7204-4A2D-A9EB-9C7A88F1C46BQ52313895-6CD67CB6-91F4-4D98-B9FA-8A2A5F7F9E8AQ57490113-DADA9E8D-6FC3-4BA0-B455-7192D45A385F
P2860
Application of IL-2 therapy to target T regulatory cell function
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Application of IL-2 therapy to target T regulatory cell function
@ast
Application of IL-2 therapy to target T regulatory cell function
@en
Application of IL-2 therapy to target T regulatory cell function
@nl
type
label
Application of IL-2 therapy to target T regulatory cell function
@ast
Application of IL-2 therapy to target T regulatory cell function
@en
Application of IL-2 therapy to target T regulatory cell function
@nl
prefLabel
Application of IL-2 therapy to target T regulatory cell function
@ast
Application of IL-2 therapy to target T regulatory cell function
@en
Application of IL-2 therapy to target T regulatory cell function
@nl
P2860
P3181
P356
P1433
P1476
Application of IL-2 therapy to target T regulatory cell function
@en
P2093
Ethan M. Shevach
P2860
P304
P3181
P356
10.1016/J.IT.2012.07.007
P407
P577
2012-12-01T00:00:00Z